Early Signs and Symptoms of IgA Nephropathy

(2:33)

IgAN \u0026 FSGS - New insights into the burden of disease and an update on emerging therapies

(5:59)

PerMed2018_PersTIgan - Development and clinical implementation of personalised management of IgAN

(2:1econd)

Is there a link between thyroid function and IgAN?

(51)

Phenotype of IgA Nephropathy and its Race/Gender-Dependent molecular mechanisms | Journal club

(8:32)

Connect, Learn and Manage IgA Nephropathy

(4:38)

Looking Upstream in IgAN The Role of the Gut and Its Implications

(36:12)

The Pathogenesis of IgA Nephropathy and Future Treatment Options. ft Dana Rizk, MD

(1:2:15)

IgA Nephropathy - Fellow's Level Overview of Basic Pathophysiology and Treatment

(48:32)

Driving innovation for patients with FSGS and IgAN

(5:17)

Genetics and IgA nephropathy

(32:32)

IgAN and Diet 2019

(23:41)

IgA nephropathy and pregnancy

(31:55)

IgA nephropathy and novel treatments

(1:1:20)

What other tests are used to diagnose kidney disease and IgAN?

(1:27)

Explaining Sparsentan’s Full FDA Approval and Other IgA Nephropathy Therapeutic Developments

(5:35)

How is eGFR used to monitor kidney disease and IgAN?

(1:18)

An update on clinical trials and new treatments in IgA nephropathy​ (2023)

(37:16)

Driving innovation for patients with FSGS and IgAN

(1:16)

How Clinical Trials are designed and why are there more IgAN clinical trials now?

(21:49)